Nanotechnology Advances PROTACs: Transition from Basic Research to Cli

Introduction

Although small molecule inhibitors (SMIs) have provided substantial benefits to many patients as valuable targeted therapeutic agents, there are still numerous significant issues that cannot be overlooked. Firstly, traditional SMIs…